Retrospective cohort study shows elevated liver and cardiovascular risks in metabolic dysfunction-associated steatohepatitis, indicating urgent need for management.
No takes yet. Share an insight, caveat, or question.
Gbadamosi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: